Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spok Holdings (SPOK) Research & Development (2016 - 2025)

Historic Research & Development for Spok Holdings (SPOK) over the last 10 years, with Q3 2025 value amounting to $3.0 million.

  • Spok Holdings' Research & Development rose 572.24% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year increase of 53.45%. This contributed to the annual value of $11.5 million for FY2024, which is 947.01% up from last year.
  • Spok Holdings' Research & Development amounted to $3.0 million in Q3 2025, which was up 572.24% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Spok Holdings' Research & Development registered a high of $6.5 million during Q1 2022, and its lowest value of $2.2 million during Q3 2022.
  • Its 5-year average for Research & Development is $3.3 million, with a median of $3.0 million in 2024.
  • In the last 5 years, Spok Holdings' Research & Development surged by 5090.78% in 2021 and then tumbled by 6162.84% in 2023.
  • Over the past 5 years, Spok Holdings' Research & Development (Quarter) stood at $4.9 million in 2021, then plummeted by 52.98% to $2.3 million in 2022, then rose by 15.83% to $2.6 million in 2023, then fell by 1.97% to $2.6 million in 2024, then rose by 15.56% to $3.0 million in 2025.
  • Its Research & Development stands at $3.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.1 million for Q1 2025.